An Observational Study For Ambrisentan

A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension

NCT07030101 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension

NCT00170950 ·Status: TERMINATED ·Phase: PHASE3

Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension

NCT00136851 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

NCT03666351 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension

NCT00160212 ·Status: COMPLETED ·Phase: PHASE2

Fixed-Free HTN Trial

NCT03578042 ·Status: UNKNOWN ·Phase: PHASE4

Ramipril 10 mg/Day Prevention

NCT01053910 ·Status: COMPLETED ·Phase: PHASE4

Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB

NCT05212597 ·Status: UNKNOWN ·Phase: PHASE2

Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension

NCT06091176 ·Status: NOT_YET_RECRUITING ·Phase: NA

Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment

NCT00932867 ·Status: COMPLETED

Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension

NCT00289406 ·Status: COMPLETED ·Phase: PHASE3

To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone

NCT01070043 ·Status: COMPLETED ·Phase: PHASE4

A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension

NCT02277691 ·Status: COMPLETED ·Phase: PHASE3

Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.

NCT04929600 ·Status: UNKNOWN ·Phase: PHASE4

A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension

NCT03897868 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension

NCT00562614 ·Status: COMPLETED ·Phase: PHASE2

Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension

NCT00139555 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy

NCT05513937 ·Status: COMPLETED ·Phase: PHASE4

N-of-1 Trials for Blood Pressure Medications in Adults

NCT02744456 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Hypertension Control Based on Home Blood Pressure

NCT00198562 ·Status: UNKNOWN ·Phase: PHASE4

Survey to Assess Why People Are Not Responding to Treatment in Hypertension

NCT01071681 ·Status: COMPLETED

Comparision of Blood Pressure Variability Between Amlodipine and Losartan

NCT01964079 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension

NCT00425373 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg

NCT01494727 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension

NCT04936035 ·Status: COMPLETED ·Phase: PHASE2